Andrew Wong
About Andrew Wong
Andrew Horwitz is the Vice President of Product Development at Inscripta, specializing in synthetic biology, with a strong background in R&D leadership at companies like Demetrix and Amyris.
Andrew Horwitz - Vice President, Product Development
Andrew Horwitz serves as the Vice President of Product Development. With a strong background in research and development, he has been instrumental in shaping innovative strategies and overseeing product advancements at various organizations.
Andrew Horwitz Education and Expertise
Andrew Horwitz holds a PhD from Harvard Medical School and a BA from Pomona College. Additionally, he was a Jane Coffin Childs Postdoctoral Fellow, further enriching his expertise in his field. His educational background has equipped him with a deep understanding of biological sciences and product development.
Andrew Horwitz Background in R&D
Andrew Horwitz has dedicated over a decade to leading R&D efforts. He has notable experience from his tenure at Demetrix and Amyris, where he played key roles in advancing research and development projects. At Sestina Bio, he established and managed the R&D team, spearheading the development of a manufacturing-focused technical thesis and platform.
Andrew Horwitz at Inscripta
In December 2022, Andrew Horwitz joined Inscripta as Vice President, Synbio Products following the acquisition of Sestina Bio. At Inscripta, he continues to leverage his extensive experience in synthetic biology to drive product innovation and development in collaboration with his team.